Markets By TradingView
5165
0

23.03.2020 NOVAVAX Daily Analysis

NOVAVAX  is going to begin a phase 1 clinical study of its experimental COVID  19 vaccine anytime from now till May and it is currently evaluating

23.03.2020 NOVAVAX Daily Analysis
Yazar: Zack Smith

Yayınlanma: 24 Mart 2020 10:25

Güncellenme: 10 Kasım 2024 02:35

23.03.2020 NOVAVAX Daily Analysis

NOVAVAX 11.16USD  + 7.83% NOVAVAX  is going to begin a phase 1 clinical study of its experimental COVID  19 vaccine anytime from now till May and it is currently evaluating several nanoparticle vaccine candidates to select the most promising one to go to the next level of advanced clinical testing. If the results of the Nanoflu are positive Novavax will quickly go to the U.S regulatory approval of the vaccine and investors are positive when it comes to Novavx because it had positive results in another clinical test that is why it keeps going high.
En Popüler Haberler

Yorum Yap

Yazılan yorumlar hiçbir şekilde Son Ekonomi Haberleri - Türkiye Dünya - ieconomy.io görüş ve düşüncelerini yansıtmamaktadır. Yorumlar, yazan kişiyi bağlayıcı niteliktedir.

Yorumlar

Henüz yorum yapan yok! İlk yorumu siz yapın...

Borsa, Kripto, Hisse, Emtia ve Döviz Haberleri

ieconomy: Türkiye'nin en kapsamlı ekonomi haber sitesi. Son dakika haberleri ve en güncel haberler ieconomy'da.